John N Dunn Group eyes return to profit after heavy impact of the pandemic

Construction firm John N Dunn Group says it is on track to return to profit in what it has described a year of big improvement.

The Wallsend-based building services firm said the impact of the pandemic had continued to weigh on its performance, but turnover increased 21% to £27m and a £769,422 operating loss was converted to a £206,878 profit. Overall losses of £1.5m in 2021 were narrowed to just over £104,000.

Accounts for the year to the end of March 2022 said the performance was down to a turnaround in the market and the introduction of efficiency measures. Trading was at about 85% of pre-Covid levels, and directors expected that to return in full this year.

Read more: Zytronic sounds cautious note as trading shows signs of recovery

The building services group specialises in plumbing, heating, and electrical work, and has targeted the low carbon market in recent times. Earlier this year it announced a partnership with North East-based Sanctus Consulting to install electric vehicle charging infrastructure – a move made possible by John N Dunn’s Office for Zero Emission Vehicles accreditation.

Stephen Bilclough, chief executive of the business, said: “During the year the business has further invested in their renewables department, in recognition of the growing demand in this sector. The business has MCS accreditation and, amongst other technologies, is skilled up to install photovoltaic panels, electric vehicle charging points and air source heat pumps. The business has delivered a number of significant renewable contracts in the current year with increasing numbers of further contracts scheduled going forward.

“Trading for the year ending March 23 is expected to be back at pre-pandemic levels and the business will return to profit this year. The business has won a large number of new contracts during the year, including new contracts for renewables, and has already secured a significant proportion of the workload required for the year ending March 24.”

READ NEXT:

Shield Therapeutics secures £15.1m in raise and seals deal with healthcare company

North East deals of the week: key acquisitions, contracts and investments